- Joined
- Sep 20, 2004
- Messages
- 12,102
- Reaction score
- 12,431
MODERATOR EDIT - Unrelated to rest of thread. Ignore this and read the below posts
Last edited by a moderator:
IMRT for nasal ALA is just bad because you can get a beautiful plan with a personalized bolus and skin collimation. That is just lazy. I keep seeing people mention single node RNI. It is acceptable to do RNI in these cases so i don’t quite follow.
Proton centers justify rni including imn to get coverage for breast cancer with single node.IMRT for nasal ALA is just bad because you can get a beautiful plan with a personalized bolus and skin collimation. That is just lazy. I keep seeing people mention single node RNI. It is acceptable to do RNI in these cases so i don’t quite follow.
Photon centers justify rni including imn to get IMRT coverage for breast cancer with a single nodeProton centers justify rni including imn to get coverage for breast cancer with single node.
How dare you… Never ever!!! You call yourself a rad onc!?Can we stop with breast? There is no wrong approach.
100% true on both countsPhoton centers justify rni including imn to get IMRT coverage for breast cancer with a single node
Your point?
Just speculation, but I am not sure they really would radiate imn in these situations and are using it as pretense for proton justification. Similarly, I would bet proton centers may not opt for partial breast with certain insurers for similar reasons.Photon centers justify rni including imn to get IMRT coverage for breast cancer with a single node
Your point?
Can we stop with breast? There is no wrong approach.
Yes. My point is that i think some of these docs would not treat the imns if “citing the need to treat imn” was not required to justify protons. Similarly with partial vs whole breast in favorable elderly pts. End up treating more normal tissue just to justify the modality with insurance.Isn't inclusion of imn the only prospectively evaluated use of rni. Is there anything beyond retrospective evaluation to justify doing rni without the imms?
Fair enough. I guess I'm just trying to dumb things down enough for me by pretty much always doing imms if I do nodes. In any case, I am still curious about an imrt xrt plan with imms vs a 3d plan without wrt to coverage, hotspots and nt constraints.Yes. My point is that i think some of these docs would not treat the imns if “citing the need to treat imn” was not required to justify protons. Similarly with partial vs whole breast in favorable elderly pts. End up treating more normal tissue just to justify the modality with insurance.
I reviewed a vmat Vs 3DFair enough. I guess I'm just trying to dumb things down enough for me by pretty much always doing imms if I do nodes. In any case, I am still curious about an imrt xrt plan with imms vs a 3d plan without wrt to coverage, hotspots and nt constraints.
That clinic doesn't need to be vmatting anything then. Good lordI reviewed a vmat Vs 3D
The doc sent a vmat plan with 3x heart dose
She did 3D
The secret is to treat without treating!
That’s basically the mammosite approach.The secret is to treat without treating!
Isn't inclusion of imn the only prospectively evaluated use of rni. Is there anything beyond retrospective evaluation to justify doing rni without the imms?
Thanks. I remember this one. Now that you posted it. I think there was also a paper where IMNs were treated on right and not left-sided, and those with right sided breast cancer had better dfs. In this paper too, was numerically superior, though not statistically superior.Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial - PubMed
ClinicalTrials.gov Identifier: NCT04803266.pubmed.ncbi.nlm.nih.gov
May only be useful to treat IMNs in patients with central/medial tumors with + Axillary LNs. In patients with pN1a dz and outer quadrant tumor I wouldn't routinely recommend IMN treatment.
Also - moved this to it's own thread...
Breast is the worst... again.
With a distant met reduction better than adding paclitaxel to AC and also seen on ma20 and poortmansIt’s not randomized but it’s very strong IMO
Best data like… don’t do IMN RT?Best data re: IMN treatment IMO
Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial - PubMed
ClinicalTrials.gov Identifier: NCT04803266.pubmed.ncbi.nlm.nih.gov
Best data like… don’t do IMN RT?
Or best data like… this data shows IMN RT works?
Blue dress? Gold dress?
You have support to drop it for lateral or low T stage. Medial and central you should really tryBest data like… don’t do IMN RT?
Or best data like… this data shows IMN RT works?
Blue dress? Gold dress?
Does anyone think that a single node for an UOQ L breast cance deserves RNI including imn?You have support to drop it for lateral or low T stage. Medial and central you should really try
Depends on histology and patient factors, I would say.Does anyone think that a single node for an UOQ L breast cance deserves RNI including imn?
Well
The luminal A - LRF is much more important than distant failure, while opposite is true for triple negative.
If you have a look at subgroup analyses of the trials, patients with more aggressive tumors and of younger age, seemed to have benefitted more from RNI.So, based on the old 4:1 rule, where the ratio is lower for luminal A and higher for triple negative, wouldn’t it be the opposite ?
You have support to drop it for lateral or low T stage. Medial and central you should really try
80% covering 90%, or whatever the acceptable imn constraints are, is kind of "trying."
I reviewed a vmat Vs 3D
The doc sent a vmat plan with 3x heart dose
She did 3D
All 4,000 of you residents! Next year, we’ll be up to 20,000!For current residents lurking and reading this thread:
DO NOT LEAVE RESIDENCY WITHOUT DOING A DOSIMETRY ROTATION (or at least take the time to learn how an IMRT plan is done)
You might end up at one of these aforementioned clinics.
I agree learn as much dosi as possible. I have to plan all my breast vmat cases.For current residents lurking and reading this thread:
DO NOT LEAVE RESIDENCY WITHOUT DOING A DOSIMETRY ROTATION (or at least take the time to learn how an IMRT plan is done)
You might end up at one of these aforementioned clinics.
For current residents lurking and reading this thread:
DO NOT LEAVE RESIDENCY WITHOUT DOING A DOSIMETRY ROTATION (or at least take the time to learn how an IMRT plan is done)
You might end up at one of these aforementioned clinics.
Yeah, this is a bridge too far, however much I like planning. Particularly IMRT breast/nodes. There's all sorts of tricks with virtual bolus, etc, that I don't have time for in addition to trying to locate records, coordinate care, etc.Okay, now I've gotta ask.
How much time do the self-planners spend on planning their own cases?
I have great dosi. I know enough to talk to them and point out specifics for how I want them to tweak plans.
Simple palliative stuff? Sure I'll do it myself. Sometimes faster that way.
But I'm not actually sitting there running optimizations myself and tweaking the objective values for IMRT plans.
Dosi can do all the easy plans. It's when they tell you they can't meet constraints you have to step in. When things get complicated, you have to think about drawing planning structures to optimize dose. In my experience, most dosimetrists will take your target volumes and go straight to optimization. That works fine for easy plans. Once you have target overlap with OARs and other complicating issues, that's when they need help.Okay, now I've gotta ask.
How much time do the self-planners spend on planning their own cases?
I have great dosi. I know enough to talk to them and point out specifics for how I want them to tweak plans.
Simple palliative stuff? Sure I'll do it myself. Sometimes faster that way.
But I'm not actually sitting there running optimizations myself and tweaking the objective values for IMRT plans.
Agree, there is a big difference between doing a plan yourself and knowing how to establish exactly what your expectations are with your dosimetry crew. The latter is what I would expect from a good doc. The most sophisticated example of the latter is a doc drawing out substructures to guide coverage, direct hotspots and allow for adequate regions for falloff to meet critical OAR constraints.I’ve never done a plan in 13 years
So surprised people do it
So time consuming
Oh, I've definitely used Eval structures and for complex cases I'll create optimization structures to guide dosi.Dosi can do all the easy plans. It's when they tell you they can't meet constraints you have to step in. When things get complicated, you have to think about drawing planning structures to optimize dose. In my experience, most dosimetrists will take your target volumes and go straight to optimization. That works fine for easy plans. Once you have target overlap with OARs and other complicating issues, that's when they need help.
How do you know you have great dosimetrists? Ever bench mark them?Okay, now I've gotta ask.
How much time do the self-planners spend on planning their own cases?
I have great dosi. I know enough to talk to them and point out specifics for how I want them to tweak plans.
Simple palliative stuff? Sure I'll do it myself. Sometimes faster that way.
But I'm not actually sitting there running optimizations myself and tweaking the objective values for IMRT plans.